SMC
VRTX icon

Smith, Moore & Co’s Vertex Pharmaceuticals VRTX Stock Holding History

Smith, Moore & Co’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-455
Closed -$212K – 504
2024
Q3 		$212K Buy
+455
New +$212K 0.02% 438